RT @CochraneLibrary: Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma. Read the featured news i…
Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma. Read the featured news item https://t.co/3ZTrckO1yV and the full review https://t.co/5Y0zZO9bbr #cancer #mmsm #MultipleMyeloma #oncology https://t.co/pOaYJ4k672
RT @CochraneUK: Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma. Read the featured news item ht…
RT @CochraneUK: Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma. Read the featured news item ht…
RT @CochraneUK: Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma. Read the featured news item ht…
RT @CochraneLibrary: Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma. Read the featured news i…
RT @CochraneLibrary: Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma. Read the featured news i…
RT @CochraneLibrary: Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma. Read the featured news i…
RT @CochraneLibrary: Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma. Read the featured news i…
RT @CochraneLibrary: Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma. Read the featured news i…
RT @CochraneLibrary: Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma. Read the featured news i…
RT @CochraneLibrary: Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma. Read the featured news i…
Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma. Read the featured news item https://t.co/DfQYxlEDv9 and the full review https://t.co/5Y0zZO9bbr #cancer https://t.co/chc9dUSoBf
RT @cochrane_hm: New Cochrane review comparing multiple drug combinations in the first-line treatment of adults suffering from transplant-i…
RT @cochranecollab: Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma. Read the featured news it…
RT @cochranecollab: Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma. Read the featured news it…
Reducing uncertainties in choosing first-line treatment in newly diagnosed multiple myeloma. Read the featured news item https://t.co/2KtXmYoHmd and the full review https://t.co/2JZ6B1hDjo #cancer https://t.co/bWknENxfPC
New Cochrane review comparing multiple drug combinations in the first-line treatment of adults suffering from transplant-ineligible multiple myeloma has just been published! Find it here: https://t.co/whRNIl6Ra1 #cochraneevidence #Cancer #multiplemyeloma h
New article: Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis. https://t.co/LrQCz90WiY #MMSM #MultipleMyeloma #hematology
Multiple drug combinations of #bortezomib, #lenalidomide, and #thalidomide for first-line treatment in adults with transplant-ineligible multiple myel... - PubMed - NCBI https://t.co/rikB3mZvuh #oncology